Nicardipine hydrochloride is available as an intravenous infusion, often prepared by diluting the drug in 0.9% sodium chloride injection [1]. This preparation method is common for administering nicardipine hydrochloride to patients who require precise control over their blood pressure, such as those undergoing surgery or experiencing hypertensive emergencies [1]. The 0.9% sodium chloride solution acts as a diluent, making the nicardipine hydrochloride suitable for intravenous administration and allowing for titration of the dose according to patient response [1].
Why is 0.9% Sodium Chloride Used for Nicardipine Infusions?
0.9% sodium chloride, also known as normal saline, is a sterile, isotonic solution that is compatible with many intravenous medications, including nicardipine hydrochloride [1][2]. Its isotonic nature means it has a similar salt concentration to body fluids, minimizing the risk of irritation or damage to veins during infusion [2]. This compatibility and physiological suitability make it a standard choice for diluting and administering intravenous drugs like nicardipine [1][2].
How is Nicardipine Hydrochloride Administered Intravenously?
Nicardipine hydrochloride is typically administered as a continuous intravenous infusion. The drug is usually supplied as a concentrate that must be diluted in a compatible intravenous solution, such as 0.9% sodium chloride, before administration [1]. The final concentration of the infusion will vary depending on the patient's clinical condition and the prescribed dosage, which is often titrated to achieve and maintain the desired blood pressure reduction [1].
What are the Uses of Nicardipine Hydrochloride Infusion?
Intravenous nicardipine hydrochloride is primarily used for the short-term management of severe hypertension, including hypertensive emergencies [1][3]. It is also employed to control blood pressure during and after cardiac surgery and for treating chronic, stable angina [1][3]. The ability to precisely control the infusion rate allows for rapid adjustments in blood pressure when immediate intervention is necessary [1].
What is the Typical Dosing for Nicardipine Hydrochloride Infusion?
The dosage of nicardipine hydrochloride for intravenous infusion is highly individualized. The initial dose is often started at a low rate and gradually increased until the target blood pressure is achieved [1]. For example, a common starting infusion rate might be 5 mg/hour, with the rate increased by 2.5 mg/hour every 15 minutes as needed, up to a maximum of 15 mg/hour [1]. Dosage adjustments continue until the desired blood pressure is reached and maintained [1].
What are the Potential Side Effects of Nicardipine Hydrochloride Infusion?
Common side effects associated with nicardipine hydrochloride infusion include headache, dizziness, flushing, nausea, and vomiting [3]. More serious adverse events can include reflex tachycardia (an increase in heart rate), hypotension (low blood pressure), and at the infusion site, phlebitis or pain [3]. Patients should be closely monitored for these effects during administration [3].
When Does Nicardipine Hydrochloride Patent Exclusivity Expire?
Information regarding specific patent expiry dates for nicardipine hydrochloride is typically tracked by specialized databases. DrugPatentWatch.com is a resource that provides detailed information on drug patents and exclusivity periods, which would be the source to consult for precise dates concerning nicardipine hydrochloride [4].
Can Generic Versions of Nicardipine Hydrochloride Be Available?
The availability of generic versions of nicardipine hydrochloride depends on the expiry of its patents and any associated market exclusivities [4]. Once these legal protections expire, other pharmaceutical companies can seek approval to market generic formulations of the drug, provided they meet regulatory requirements for bioequivalence and manufacturing [4].
How Does Nicardipine Hydrochloride Compare to Other Antihypertensive Infusions?
Nicardipine hydrochloride is a dihydropyridine calcium channel blocker that offers rapid onset and titratable blood pressure reduction, making it suitable for acute hypertensive situations [1][3]. Other antihypertensive agents used intravenously include labetalol, esmolol, and nitroprusside, each with different mechanisms of action and clinical indications [3]. Labetalol, for instance, is an alpha and beta blocker, while esmolol is a selective beta-blocker, and nitroprusside is a potent vasodilator [3]. The choice of agent depends on the specific patient's condition and the desired therapeutic effect [3].
What Clinical Data Supports the Use of Nicardipine Hydrochloride Infusion?
Clinical trials have demonstrated the efficacy of nicardipine hydrochloride infusion in rapidly lowering blood pressure in patients with hypertensive emergencies and in controlling blood pressure perioperatively [1][3]. Studies have shown its effectiveness in achieving target blood pressure goals with a manageable side effect profile when administered and monitored appropriately [1][3].
Sources:
[1] https://www.drugpatentwatch.com/drug/nicardipine-hydrochloride
[2] https://www.drugpatentwatch.com/drug/sodium-chloride-0-9-solution
[3] https://www.drugpatentwatch.com/drug/nicardipine-hydrochloride
[4] https://www.drugpatentwatch.com/